HIGHLIGHTS
- who: Fukashi Ishibashi from the National Institute for Health and Care Research (NIHR) Exeter Clinical Research Facility, and Institute of Biomedical and Clinical Sciences, University of Exeter Medical School, Exeter, United Kingdom have published the article: Sodium Glucose Cotransporter-2 Inhibitor Protects Against Diabetic Neuropathy and Nephropathy in Modestly Controlled Type 2 Diabetes: Follow-Up Study, in the Journal: (JOURNAL)
- what: The glycemic variability calculated from monthly measured HbA1c and CPPG levels in this study was more representative than CGM parameters evaluated merely at the endpoint.
- how: These results indicated that SGLT2i exerted . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.